Sinew Pharma Inc. (TPEX:6634)
35.30
+0.35 (1.00%)
Jan 21, 2026, 1:30 PM CST
Sinew Pharma Market Cap
Sinew Pharma has a market cap or net worth of 2.59 billion as of January 21, 2026. Its market cap has decreased by -20.85% in one year.
Market Cap
2.59B
Enterprise Value
1.50B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
35.30
Market Cap Chart
Since June 29, 2017, Sinew Pharma's market cap has increased from 1.90B to 2.59B, an increase of 36.19%. That is a compound annual growth rate of 3.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 2.49B | -10.73% |
| Dec 31, 2025 | 2.79B | -17.68% |
| Dec 31, 2024 | 3.39B | -29.30% |
| Dec 29, 2023 | 4.80B | -34.51% |
| Dec 30, 2022 | 7.33B | 29.47% |
| Dec 30, 2021 | 5.66B | 19.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 254.20B |
| PharmaEssentia | 213.40B |
| Lotus Pharmaceutical | 84.02B |
| Heron Neutron Medical | 69.56B |
| Bora Pharmaceuticals Co., LTD. | 65.48B |
| Oneness Biotech | 33.73B |
| Lumosa Therapeutics | 31.25B |
| Center Laboratories | 31.09B |